Top Markets
Coin of the day
China Medicine Corp. China Medicine Corp.

China Medicine Corp.

CHME
Rank in Stocks #38472
China Medicine Corporation produces and distributes prescription and over the... China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Share Price
$0.0406
Last synced: 2026-08-13
Market Cap
$962.71K
Change (1 day)
0.00%
Change (1 year)
6,666.67%
Country
CN
Trade China Medicine Corp. (CHME)

Category

EPS for China Medicine Corp. (CHME)
EPS as of 2026 TTM: 0
According to China Medicine Corp. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for China Medicine Corp. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors